Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_assertion evidence source_evidence_literature NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_assertion SIO_000772 22802388 NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_assertion wasDerivedFrom befree-20140225 NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_assertion wasGeneratedBy ECO_0000203 NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.